HCPLive Network
  • AHA 2014
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Friday, December 19, 2014
By Jeannette Y. Wick, RPh, MBA, FASCP
Atherosclerotic internal carotid artery disease is a major contributor to ischemic stroke. Surgeons use a combination of carotid artery and brain imaging to determine if patients have symptomatic carotid stenosis. However, there remains widespread disagreement on the threshold, timing, and best technical approach to carotid revascularization in symptomatic patients.
Friday, December 19, 2014
By Jeannette Y. Wick, RPh, MBA, FASCP
Slightly more than 6.8 million community-dwelling Americans use assistive devices (eg, canes, walkers, crutches) to help them with mobility and, of these, 1.7 million people use wheelchairs or scooter riders. These Americans at risk for unique musculoskeletal problems, especially rotator cuff injuries.
Friday, December 19, 2014
By Rachel Lutz
The FDA has cleared a blood test that can screen patients, especially black women, for coronary heart disease.
Friday, December 19, 2014
By Rachel Lutz
The chemical compound indazole chloride (Ind-Cl) initiated long lasting relief in mice models of multiple sclerosis.
Friday, December 19, 2014
By Adam Hochron
The US Food and Drug Administration has announced the approval of a new combination treatment for hepatitis C virus.
Friday, December 19, 2014
Predictors have been identified for referral-warranted-retinopathy of prematurity, according to research published online Dec. 18 in JAMA Ophthalmology.
Friday, December 19, 2014
For patients with melanoma arising in head and neck subsites, there is no association between sentinel lymph node biopsy and disease-specific survival, according to research published in the December issue of JAMA Otolaryngology-Head & Neck Surgery.
Friday, December 19, 2014
For patients with bladder cancer, laparoscopic radical cystectomy is associated with good long-term outcomes, according to research published online Dec. 18 in BJU International.
Friday, December 19, 2014
For pharmacy graduates and tutors, evidence seems to play a limited role in over-the-counter decision making, according to a study published online Dec. 11 in the Journal of Evaluation in Clinical Practice.
Friday, December 19, 2014
For older patients, a shared medical appointment program facilitates early detection and referral for geriatric syndromes, according to an article published online Nov. 29 in the Journal of the American Geriatrics Society.
Friday, December 19, 2014
By Gale Scott
It’s been a good year for heart disease and stroke research. An expert panel chosen by the American Heart Association and American Stroke Association recently named 2014’s most significant research news events.
Friday, December 19, 2014
A high-dose influenza vaccine produces a stronger immune response than the standard vaccine in frail seniors under care in nursing homes, according to a new study published online Dec. 17 in the Journal of Infectious Diseases.
Email Signup
Breaking News
The US Food and Drug Administration has announced the approval of a new combination treatment for hepatitis C virus.
The US Food and Drug Administration (FDA) approved today Xtoro (finafloxacinotic suspension), a novel drug treatment for acute otitis externa, otherwise known as swimmer’s ear, an infection within the outer ear and ear canal, typically caused by bacteria festered in the ear canal.
Officials at a Swiss hospital today announced they are temporarily halting trials of VSV-ZEBOV, the Ebola vaccine from Merck and NewLink. The trial is being conducted at Hopitaux Universitaires de Geneve. The trials will resume on Jan. 5, 2015. The decision was made after 4 volunteers developed mild joint pain in their hands and feet from 10 to 15 days after being vaccinated. There are 59 volunteers participating in the trial at the Swiss site.
Physician's Money Digest
The end of the year has a number of significant financial implications that we should not lose sight of in our merriment. And being aware of some of them will allow us to feel better and maybe save some money, even if we are sometimes profligate in our holiday shopping.
Fredy Revilla, MD, never met a mountain he didn’t like. The neurologist has found a connection between his passion for climbing and his profession of caring for patients with neurological disorders.
Product News
The US Food and Drug Administration today approved Merck’s Gardasil 9, a vaccine that offers protection against 5 more types of Human Papillomavirus (HPV) than original Gardasil. In addition to preventing cervical, vulvar, vaginal and anal cancers caused by HPV types 16 and 18 (those prevented by the older version of Gardasil) Gardasil 9 also prevents those cancers caused by HPV strains 31, 33, 45, 52, and 58.
Obizur (Antihemophilic Factor [Recombinant], Porcine Sequence) has been approved to treat acquired hemophilia A (acquired Factor VIII deficiency), a rare, non-inherited form of hemophilia.
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
HCPLive Poll
Twitter Advice
Have you ever given medical or financial advice on Twitter?